2,4-Dichloro-5-fluoro-6-methylpyrimidine

Catalog No. :
ACDQEP950
CAS No. :
954220-98-5
Molecular Formula :
C5H3Cl2FN2
Molecular Weight :
181.00

IUPAC Name:2,4-dichloro-5-fluoro-6-methylpyrimidine

2,4-Dichloro-5-fluoro-6-methylpyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$53.00Login to see priceIn stockInquiry
5g95%$158.00Login to see priceIn stockIn stock
10g95%$268.00Login to see priceIn stockIn stock
25g95%$534.00Login to see priceIn stockInquiry
100g95%$1704.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,4-Dichloro-5-fluoro-6-methylpyrimidine
IUPAC Name2,4-dichloro-5-fluoro-6-methylpyrimidine
MDL No.MFCD09863051
Molecular FormulaC5H3Cl2FN2
Molecular Weight181.00
SMILESCC1=C(F)C(Cl)=NC(Cl)=N1
InChI KeyIYGLMCCNOPCDCR-UHFFFAOYSA-N
SynonymSCHEMBL12599932 | IYGLMCCNOPCDCR-UHFFFAOYSA-N | DTXSID30647942 | SY021590 | CS-0039159 | 2,4-dichloro-5-fluoro-6-methylpyrimidine | 2,4-dichloro-5-fluoro-6-methyl-pyrimidine | Z1198234957 | DS-10130 | MFCD09863051 | AKOS006312029 | EN300-126886 | SB57777
CAS No.954220-98-5
PubChem CID24903513

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACDQEP950 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDQEP950 route product structure diagram
    ACDQEP950954220-98-5 In Stock
Inquiry

2. ACDQEP950 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCWDA697 route compound structure diagram
    ACCWDA69713061-96-6
  2. Plus
  3. ACTEHZ752 route compound structure diagram
    ACTEHZ7526693-08-9 In Stock
  4. Then
  5. ACDQEP950 route product structure diagram
    ACDQEP950954220-98-5 In Stock
Inquiry

Comments (0)